MAPT and Alzheimer disease: In human genetic studies, microglia has been shown to have high expression of numerous AD risk genes, and in recent investigations using tau mouse models, depleting microglia effectively reduced tau seeding activity1,2, curbed neuroinflammation, and mitigated tau-related neurodegeneration3,4.